Jeffrey Graham, MD, Talks Immunotherapy Use in Frontline Non-Clear Cell RCC
CancerNetwork® sat down with Jeffrey Graham, MD, FRCPC, to discuss the effectiveness of immune checkpoint inhibitors as frontline therapy for non–clear cell renal cell carcinoma